INNOVATIVE CLINICAL SOLUTIONS LTD

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

5

4,5,7

4,7

4,5,7

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Annual report pursuant to Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Notification of late filing of Form 10-K

5,7

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

2,5

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

No description available

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Definitive information statement

No description available

5,7

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

5,7

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

1,5,7

General form for quarterly reports under Section 13 or 15(d) (amendment)

No description available

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

3,7

3,7

Tender offer statement by the issuer (amendment)

4,7

4,7

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

5

Tender offer statement by the issuer

Annual report pursuant to Section 13 or 15(d)

5,7

3

Notification of late filing of Form 10-K

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

2,7

General form for quarterly reports under Section 13 or 15(d)

5

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Registration statement under Securities Act of 1933 (amendment)

Prospectus Supplement for Primary Offering

5

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

5

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Definitive Proxy Statement

Definitive Proxy Statement